6533b836fe1ef96bd12a0a01

RESEARCH PRODUCT

Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin

Maen ZeinoThomas EfferthTolga EichhornAnbazhagan VeerappanDirk Schneider

subject

Drugmedia_common.quotation_subjectmedicine.medical_treatmentSerum albuminArtesunatePharmaceutical ScienceDihydroartemisininPharmacologyHydrophobic effectchemistry.chemical_compoundBlood serumparasitic diseasesDrug DiscoverymedicineAnimalsArtemisininSerum Albuminmedia_commonPharmacologybiologyChemistryArtemisininsReceptor–ligand kineticsMalariaComplementary and alternative medicineBiochemistryArtesunatebiology.proteinMolecular MedicineCattleDrug Therapy CombinationHydrophobic and Hydrophilic InteractionsProtein Bindingmedicine.drug

description

Artemisinin is a drug, widely used in malaria treatment. As the binding affinity of artemisinin and its derivatives dihydroartemisinin and artesunate to blood serum proteins might influence the effectiveness of the drug, binding of artemisinin and derivatives to serum albumin was studied under near physiological conditions. Binding kinetics indicate a simple, single-step association process for all artemisinin derivatives. The determined changes in enthalpy and entropy upon drug binding clearly indicate that hydrophobic forces are most important for artemisinin and dihydroartemisinin binding, whereas binding of artesunate is governed by both hydrophilic and hydrophobic forces. Key residues, which are most likely involved in binding of the respective compounds, were identified in subsequent protein/drug docking studies. The obtained results not only explain differences in between artemisinin and derivatives but generally illustrate how slight modifications in a drug can significantly affect principles underlying drug binding to target proteins.

https://doi.org/10.1016/j.phymed.2013.04.003